Published and in press
Original research
Henri Schmidt, Minsi Zhang, Dimitar Chakarov, Vineet Bansal, Haralambos Mourelatos, Francisco J Sánchez-Rivera, Scott W Lowe, Andrea Ventura, Christina S Leslie, Yuri Pritykin. Genome-wide CRISPR guide RNA design and specificity analysis with GuideScan2. Genome Biology 26, 41 (2025).
Imran Noorani, Magnus Haughey, Jens Luebeck, Andrew Rowan, Eva Grönroos, Francesco Terenzi, Ivy Tsz-Lo Wong, Davide Pradella, Marta Lisi, Jeanette Kittel, Natasha Sharma, Chris Bailey, Clare E Weeden, Donald M Bell, Eric Joo, Vittorio Barbè, Matthew G Jones, King L Hung, Emma L Nye, Mary Green, Lucy Meader, Emma J Norton, Mark Fabian, Nnennaya Kanu, Mariam Jamal-Hanjani, Thomas Santarius, Andrea Ventura, James AR Nicoll, Delphine Boche, Howard Y Chang, Vineet Bafna, Weini Huang, Paul S Mischel, Charles Swanton, Benjamin Werner. Extrachromosomal DNA–Driven Oncogene Spatial Heterogeneity and Evolution in Glioblastoma. Cancer Discovery (2025) 15 (10): 2078–2095.
Alyssa Shepard, Daniel K Lester, Scott Troutman, Sany Hoxha, Walid T Khaled, Ewan St J Smith, Thomas J Park, Rochelle Buffenstein, Dongliang Du, Mingxiang Teng, Christine M Dengler-Crish, Kenneth Y Tsai, Elsa R Flores, Andrea Ventura, Joseph L Kissil. Cancer Discovery 2026;XX:1–11.
Brückner L, Xu R, Tang J, Herrmann A, Wong IT, Zhang S, Tu F, Pilon M, Kukalev A, Pardon K, Sidorova O, Atta J, Yu Q, Pradella D, Ilić M, Marco-Novais-Cruz, Kaltenbach S, Treue D, Giurgiu M, Herzog S, Hollinger AS, Fernandez M, Becker F, Louma VR, Schmargon R, Dörr J, Gamlin D, Lehmann A, Gürgen D, Richter M, Dubois F, Simeoni F, Pennycook BR, Hamilton A, Lindemann RK, Fischer M, Bafna V, Wahl G, Koche RP, Chang HY, Papathanasiou S, Medema R, Spanjaard B, Ventura A, Pombo A, Huang W, Werner B, Mischel PS, Henssen AG. Oncogene Silencing via ecDNA Micronucleation. bioRxiv [Preprint]. 2025 Apr 18:2025.04.15.648906.
Davide Pradella, Minsi Zhang1, Rui Gao, Melissa A. Yao, Katarzyna M. Gluchowska, Ylenia Cendon-Florez, Tanmay Mishra, Gaspare La Rocca, Moritz Weigl, Ziqi Jiao, Hieu H. M. Nguyen, Marta Lisi, Mateusz M. Ozimek, Chiara Mastroleo, Kevin Chen, Felix Grimm, Jens Luebeck, Shu Zhang, Andrea Alice Zolli, Eric G. Sun, Bhargavi Dameracharla, Zhengqiao Zhao, Yuri Pritykin, Carlie Sigel, Howard Y. Chang, Paul S. Mischel, Vineet Bafna, Cristina R. Antonescu & Andrea Ventura. Engineered extrachromosomal oncogene amplifications promote tumorigenesis. Nature 637, 955–964 (2025). PMID: 39695225.
Alyssa Shepard, Scott Troutman, Sany Hoxha, Daniel Lester, Walid Khaled, Ewan St. John Smith, Thomas Park, Rochelle Buffenstein, Dongliang DuMingxiang Teng, Christine Crish, Kenneth Y. Tsai, Elsa R. Flores, Andrea Ventura, Joseph L. Kissil An autochthonous model of lung cancer in the Naked Mole-Rat (Heterocephalus glaber). bioRxiv 2023:2023.08. 28.555115.
Zhen Qin, Meiting Yue, Shijie Tang, Fengying Wu, Honghua Sun, Yuan Li, Yongchang Zhang, Hiroki Izumi, Hsinyi Huang, Wanying Wang, Yun Xue, Xinyuan Tong, Shunta Mori, Tetsuro Taki, Koichi Goto, Yujuan Jin, Fei Li, Fu-Ming Li, Yijun Gao, Zhaoyuan Fang, Yisheng Fang, Liang Hu, Xiumin Yan, Guoliang Xu, Haiquan Chen, Susumu S Kobayashi, Andrea Ventura, Kwok-Kin Wong, Xueliang Zhu, Liang Chen, Shengxiang Ren, Luo-Nan Chen, Hongbin Ji. EML4-ALK fusions drive lung adeno-to-squamous transition through JAK-STAT activation. Journal of Experimental Medicine 2024;221(3):e20232028.
Paola Roa, Valentina Foglizzo, Guilherme Harada, Matteo Repetto, Amanda Kulick, Elisa de Stanchina, Michelle de Marchena, Supipi Auwardt, Shaza Sayed Ahmed, Nicole Virginia Bremer, Soo-Ryum Yang, Yangbo Feng, Chao Zhou, Norman Kong, Ruixia Liang, Haipeng Xu, Bin Zhang, Alberto Bardelli, Eneda Toska, Andrea Ventura, Alexander Drilon, Emiliano Cocco. Zurletrectinib is a next-generation TRK inhibitor with strong intracranial activity against NTRK fusion-positive tumours with on-target resistance to first-generation agents. British Journal of Cancer 2024:1-10.
Schmidt H, Zhang M, Mourelatos H, Sánchez-Rivera FJ, Lowe SW, Ventura A, Leslie CS, Pritykin Y. Genome-wide CRISPR guide RNA design and specificity analysis with GuideScan2. bioRxiv 2022:2022.05. 02.490368.
Shui B, Beyett TS, Chen Z, Li X, La Rocca G, Gazlay WM, Eck MJ, Lau KS, Ventura A, Haigis KM. Oncogenic K-Ras suppresses global miRNA function. Molecular Cell 2023;83(14):2509-23. e13.
La Rocca G, King B, Shui B, Li X, Zhang M, Akat KM, Ogrodowski P, Mastroleo C, Chen K, Cavalieri V, Ma Y, Anelli V, Betel D, Vidigal J, Tuschl T, Meister G, Thompson CB, Lindsten T, Haigis K, Ventura A. Inducible and reversible inhibition of miRNA-mediated gene repression in vivo. Elife 2021 Aug 31;10:e70948. doi: 10.7554/eLife.70948. PMID: 34463618; PMCID: PMC8476124.
Ciampricotti M, Karakousi T, Richards AL, Quintanal-Villalonga À, Karatza A, Caeser R, Costa EA, Allaj V, Manoj P, Spainhower KB, Kombak FE, Sanchez-Rivera FJ, Jaspers JE, Zavitsanou AM, Maddalo D, Ventura A, Rideout WM, Akama-Garren EH, Jacks T, Donoghue MTA, Sen T, Oliver TG, Poirier JT, Papagiannakopoulos T, Rudin CM. Rlf-Mycl Gene Fusion Drives Tumorigenesis and Metastasis in a Mouse Model of Small Cell Lung Cancer. Cancer Discovery 2021 Dec 1;11(12):3214-3229. doi: 10.1158/2159-8290.CD-21-0441. PMID: 34344693; PMCID: PMC8810895.
Li X, Pritykin Y, Concepcion CP, Lu Y, La Rocca G, Zhang M, King B, Cook PJ, Au YW, Popow O, Paulo JA, Otis HG, Mastroleo C, Ogrodowski P, Schreiner R, Haigis KM, Betel D, Leslie CS, Ventura A. High-Resolution In Vivo Identification of miRNA Targets by Halo-Enhanced Ago2 Pull-Down. Molecular Cell 2020 May 29: S1097-2765(20)30310-5. doi: 10.1016/j.molcel.2020.05.009. Epub ahead of print. PMID: 32497496.
Cocco E., J.E. Lee, S. Kannan, A.M. Schram, H.H. Won, S. Shifman, A. Kulick, L. Baldino, E. Toska, A. Arruabarrena-Aristorena, S. Kittane, F. Wu, Y. Cai, S. Arena, B. Mussolin, R. Kannan, N. Vasan, A.N. Gorelick, M.F. Berger, O. Novoplansky, S. Jagadeeshan, Y. Liao, U. Rix, S. Misale, B.S. Taylor, A. Bardelli, J.F. Hechtman, D.M. Hyman, M. Elkabets, E. de Stanchina, C.S. Verma, A. Ventura, A. Drilon, and M. Scaltriti, TRK xDFG mutations trigger a sensitivity switch from type I to II kinase inhibitors. Cancer Discovery 2020.
Luisa F. Escobar-Hoyos, Alex Penson, Ram Kannan, Hana Cho, Chun-Hao Pan, Rohit K. Singh, Lisa H. Apken, G. Aaron Hobbs, Renhe Luo, Nicolas Lecomte, Sruthi Babu, Fong Cheng Pan, Direna Alonso-Curbelo, John P. Morris IV, Gokce Askan, Olivera Grbovic-Huezo, Paul Ogrodowski, Jonathan Bermeo, Joseph Saglimbeni, Cristian D. Cruz, Yu-Jui Ho, Sharon A. Lawrence, Jerry P. Melchor, Grant A. Goda, Karen Bai, Alessandro Pastore. Simon J. Hogg. Srivatsan Raghavan, Peter Bailey, David K. Chang, Andrew Biankin, Kenneth R. Shroyer, Brian M. Wolpin. Andrew J. Aguirre, Andrea Ventura, Barry Taylor, Channing J. Der, Daniel Dominguez, Daniel Kümmel, Andrea Oeckinghaus, Scott W. Lowe, Robert K. Bradley, Omar Abdel-Wahab, Steven D. Leach. Altered RNA Splicing by Mutant p53 Activates Oncogenic RAS Signaling in Pancreatic Cancer. Cancer Cell, June 18, 2020, DOI: https://doi.org/10.1016/j.ccell.2020.05.010.
Bonetti P, Climent M, Panebianco F, Tordonato C, Santoro A, Marzi MJ, Pelicci PG, Ventura A, Nicassio F. Correction: Dual role for miR-34a in the control of early progenitor proliferation and commitment in the mammary gland and in breast cancer. Oncogene 2020 Mar;39(10):2228. doi: 10.1038/s41388-019-1094-x.
Zheng J, Sadot E, Vigidal JA, Klimstra DS, Balachandran VP, Kingham TP, Allen PJ, D’Angelica MI, DeMatteo RP, Jarnagin WR, and Ventura A. Characterization of hepatocellular adenoma and carcinoma using microRNA profiling and targeted gene sequencing. PLoS One 2018 Jul 27;13(7): e0200776. doi: 10.1371/journal.pone.0200776. eCollection 2018. PubMed PMID: 30052636; PubMed Central PMCID: PMC6063411.
Franz X. Schaub, Varsha Dhankani, Ashton C. Berger, Mihir Trivedi, Anne B. Richardson, Reid Shaw, Wei Zhao, Xiaoyang Zhang, Andrea Ventura, Yuexin Liu, Donald E. Ayer, Peter J. Hurlin, Andrew D. Cherniack, Robert N. Eisenman, Brady Bernard, Carla Grandori and the Cancer Genome Atlas Network. Cell Systems 2018 Mar 28;6(3):282-300.e2. doi: 10.1016/j.cels.2018.03.003.
Perez, A.&, Pritykin, Y.&, Vidigal, J.&*, Chhangawala, S., Zamparo, L., Leslie, C.*, and Ventura, A. GuideScan software for improved single and paired CRISPR guide RNA design. Nature Biotechnology 2017 Apr;35(4):347-349. PMID: 28263296. PMCID: PMC5607865 (* corresponding authors, & equally contributing authors)
Cook PJ, Thomas R, Kannan R, de Leon ES, Drilon A, Rosenblum MK, Scaltriti M, Benezra R, Ventura A. Somatic chromosomal engineering identifies BCAN-NTRK1 as a potent glioma driver and therapeutic target. Nature Communications 2017;8:15987. PubMed PMID: 28695888 PMCID:PMC5508201.
Andolina, D., Di Segni, M., Bisicchia, E., D’Alessandro, F., Cestari, V., Ventura, A., Concepcion, C., Puglisi-Allegra, S., and Ventura, R. (2016). Effects of lack of microRNA-34 on the neural circuitry underlying the stress response and anxiety. Neuropharmacology 107, 305-316.
Correa-Gallego, C., Maddalo, D., Doussot, A., Kemeny, N., Kingham, T.P., Allen, P.J., D’Angelica, M.I., DeMatteo, R.P., Betel, D., Klimstra, D., et al. (2016). Circulating Plasma Levels of MicroRNA-21 and MicroRNA-221 Are Potential Diagnostic Markers for Primary Intrahepatic Cholangiocarcinoma. PLoS One 11, e0163699
Joana A. Vidigal and Andrea Ventura. Rapid and efficient one-step generation of paired gRNA CRISPR/Cas9 libraries. Nature Communications 2015Aug 17; 6:8083. doi: 10.1038/ncomms9083. PubMed PMID: 26278926.
Yoon-Chi Han*, Joana A. Vidigal*, Ping Mu*, Evelyn Yao, Irtisha Singh, Alvaro Gonzalez, Carla P. Concepcion, Ciro Bonetti, Paul Ogrodowski, Brett Carver, Licia Selleri, Christina Leslie, Doron Betel, and Andrea Ventura. An allelic series of miR-17~92 mutant mice uncovers functional specialization and cooperation among members of a miRNA polycistron. Nature Genetics 2015 Jun 1. doi: 10.1038/ng.3321. [Epub ahead of print] PubMed PMID: 26029871. *Equal contibution.
Fiori E, Babicola L, Andolina D, Coassin A, Pascucci T, Patella L, Han YC, Ventura A, Ventura R. Neurobehavioral Alterations in a Genetic Murine Model of Feingold Syndrome 2. Behavior Genetics 2015 Sep;45(5):547-59. doi: 10.1007/s10519-015-9724-8. Epub 2015 May 31. PMID: 26026879; PMCID: PMC4561592.
La Rocca G, Olejniczak SH, González AJ, Briskin D, Vidigal JA, Spraggon L, DeMatteo RG, Radler MR, Lindsten T, Ventura A, Tuschl T, Leslie CS, Thompson CB. In vivo, Argonaute-bound microRNAs exist predominantly in a reservoir of low molecular weight complexes not associated with mRNA. Proceedings of the National Academy of Science U. S. A. 2015 Jan 20;112(3):767-72. doi: 10.1073/pnas.1424217112. Epub 2015 Jan 7. PMID: 25568082; PMCID: PMC4311832.
Danilo Maddalo, Eusebio Manchado, Carla P. Concepcion, Ciro Bonetti, Joana A. Vidigal, Yoon-Chi Han, Paul Ogrodowski, Alessandra Crippa, Natasha Rekhtman, Elisa de Stanchina, Scott W. Lowe, and Andrea Ventura. In vivo engineering of oncogenic chromosomal rearrangements with the CRISPR/Cas9 system. Nature (2014) NIHMS:NIHMS632589 PMID: PMID: 25337876.
Frederique Zindy, Daisuke Kawauchi, Youngsoo Lee, Olivier Ayrault, Leila Ben Merzoug, Peter J. McKinnon, Andrea Ventura and Martine F. Roussel. Role of the miR-17 approximately 92 cluster family in cerebellar and medulloblastoma development. Biology Open 3, 597-605 (2014). PMCID: PMC4154296.
Carla P. Concepcion, Yoon-Chi Han, Ping Mu, Ciro Bonetti, Evelyn Yao, Aleco D’Andrea, Joana A. Vidigal, William P. Maughan, Paul Ogrodowski and Andrea Ventura . Intact p53-dependent responses in miR-34-deficient mice. PLoS Genetics 8, e1002797 (2012). PMCID: PMC3406012.
Jr-Shiuan Yang, Michael D. Phillips, Doron Betel, Ping Mu, Andrea Ventura, Adam C. Siepel, Kevin C. Chen and Eric C. Lai. Widespread regulatory activity of vertebrate microRNA* species. RNA 17, 312-326 (2011). PMCID: PMC3022280
Ashish Lal, Marshall P. Thomas, Gabriel Altschuler, Francisco Navarro, Elizabeth O’Day, Xiao Ling Li, Carla Concepcion, Yoon-Chi Han, Jerome Thiery, Danielle K. Rajani, Aaron Deutsch, Oliver Hofmann, Andrea Ventura, Winston Hide and Judy Lieberman. Capture of microRNA-bound mRNAs identifies the tumor suppressor miR-34a as a regulator of growth factor signaling. PLoS Genetics 7, e1002363 (2011). PMCID: PMC3213160.
Loïc de Pontual&, Evelyn Yao&, Patrick Callier, Laurence Faivre, Valérie Drouin, Sandra Cariou, Arie Van Haeringen, David Geneviève, Alice Goldenberg, Myriam Oufadem, Sylvie Manouvrier, Arnold Munnich, Joana Alves Vidigal, Michel Vekemans, Stanislas Lyonnet, Alexandra Henrion-Caude, Andrea Ventura* and Jeanne Amiel*. Germline deletion of the miR-17 approximately 92 cluster causes skeletal and growth defects in humans. Nature Genetics 43, 1026-1030 (2011). *corresponding authors. & Equal contribution. PMCID: PMC3184212
Massimiliano Agostini, Paola Tucci, Joern R. Steinert, Ruby Shalom-Feuerstein, Matthieu Rouleau, Daniel Aberdam, Ian D. Forsythe, Kenneth W. Young, Andrea Ventura, Carla P. Concepcion, Yoon-Chi Han, Eleonora Candi, Richard A. Knight, Tak W. Mak and Gerry Melino. microRNA-34a regulates neurite outgrowth, spinal morphology, and function. Proceedings of the National Academy of Science U.S.A. 108, 21099-21104 (2011). PMCID: PMC3248521
Ping Mu*, Yoon-Chi Han*, Doron Betel, Evelyn Yao, Massimo Squatrito, Paul Ogrodowski, Elisa de Stanchina, Aleco D’Andrea, Chris Sander and Andrea Ventura. Genetic dissection of the miR-17~92 cluster of microRNAs in Myc-induced B-cell lymphomas. Genes & Development 23, 2806-2811 (2009). PMCID: PMC2800095. *Equal contibution.
Andrea Ventura, Amanda G. Young, Monte M. Winslow, Laura Lintault, Alex Meissner, Stefan J. Erkeland, Jamie Newman, Roderick T. Bronson, Denise Crowley, James R. Stone, Rudolf Jaenisch, Phillip A. Sharp and Tyler Jacks. Targeted deletion reveals essential and overlapping functions of the miR-17 through 92 family of miRNA clusters. Cell 132, 875-886 (2008). PMCID: PMC2323338.
Andrea Ventura*, David G. Kirsch*, Margaret E. McLaughlin, David A. Tuveson, Jan Grimm, Laura Lintault, Jamie Newman, Elizabeth E. Reczek, Ralph Weissleder and Tyler Jacks. Restoration of p53 function leads to tumour regression in vivo. Nature 445, 661-665 (2007). *equal contribution. PubMed PMID: 17251932 *Equal contibution.
Alfredo Pezzicoli, Cristina Ulivieri, Nagaja Capitani, Andrea Ventura, Piergiuseppe Pelicci and Cosima T. Baldari. Expression in T-cells of the proapoptotic protein p66SHC is controlled by promoter demethylation. Biochemical and Biophysical Research Communication 349, 322-328 (2006). PubMed PMID: 16934220
Andrea Ventura*, Alexander Meissner*, Christopher P. Dillon, Michael McManus, Phillip A. Sharp, Luk Van Parijs, Rudolf Jaenisch and Tyler Jacks. Cre-lox-regulated conditional RNA interference from transgenes. Proceedings of the National Academy of Science U.S.A. 101, 10380-10385 (2004). *equal contribution PMCID: PMC478580. *Equal contibution.
Andrea Ventura, Marco Maccarana, Veronica A. Raker and Pier Giuseppe Pelicci. A cryptic targeting signal induces isoform-specific localization of p46Shc to mitochondria. Journal of Biological Chemistry 279, 2299-2306 (2004).
Sonia Pacini, Michela Pellegrini, Enrica Migliaccio, Laura Patrussi, Cristina Ulivieri, Andrea Ventura, Fabio Carraro, Antonella Naldini, Luisa Lanfrancone, Piergiuseppe Pelicci and Cosima T. Baldari. p66SHC promotes apoptosis and antagonizes mitogenic signaling in T cells. Molecular and Cellular Biology 24, 1747-1757 (2004). PMCID: PMC344195.
M. Mandala, G. Curigliano, P. Bucciarelli, G. Ferretti, P. M. Mannucci, M. Colleoni, A. Ventura, G. Peruzzotti, G. Severi, P. G. Pelicci, R. Biffi, F. Orsi, S. Cinieri and A. Goldhirsch. Factor V Leiden and G20210A prothrombin mutation and the risk of subclavian vein thrombosis in patients with breast cancer and a central venous catheter. Annals of Oncology 15, 590-593 (2004).
Andrea Ventura, Lucilla Luzi, Sonia Pacini, Cosima T. Baldari and Pier Giuseppe Pelicci. The p66Shc longevity gene is silenced through epigenetic modifications of an alternative promoter. Journal of Biological Chemistry 277, 22370-22376 (2002).
Mirella Trinei, Marco Giorgio, Angelo Cicalese, Sara Barozzi, Andrea Ventura, Enrica Migliaccio, Elisabetta Milia, Ines Martin Padura, Veronica A. Raker, Marco Maccarana, Valeria Petronilli, Saverio Minucci, Paolo Bernardi, Luisa Lanfrancone and Pier Giuseppe Pelicci. A p53-p66Shc signalling pathway controls intracellular redox status, levels of oxidation-damaged DNA and oxidative stress-induced apoptosis. Oncogene21, 3872-3878 (2002).
M. Cervellera, G. Raschella, G. Santilli, B. Tanno, A. Ventura, C. Mancini, C. Sevignani, B. Calabretta and A. Sala. Direct transactivation of the anti-apoptotic gene apolipoprotein J (clusterin) by B-MYB. Journal of Biological Chemistry 275, 21055-21060 (2000).
M. Genuardi, A. Viel, D. Bonora, E. Capozzi, A. Bellacosa, F. Leonardi, R. Valle, A. Ventura, M. Pedroni, M. Boiocchi and G. Neri. Characterization of MLH1 and MSH2 alternative splicing and its relevance to molecular testing of colorectal cancer susceptibility. Human Genetics 102, 15-20 (1998).
Reviews and commentaries
Davide Pradella, Andrea Ventura. Not just a by-product: circular DNA molecules derived from V(D)J recombination are linked to worse prognosis in B-cell leukemia. Molecular Oncology 19 (2025) 2999–3002.
Shui B, La Rocca G, Ventura A, Haigis KM. Interplay between K-RAS and miRNAs. Trends in cancer. 2022;8(5):384-96.
X Li, A Ventura. ALK7 Erects a Suppressive Barrier to Tumor Progression and Metastasis
Developmental Cell 49 (3), 304-305.
Cook, P.J., and Ventura, A. (2019). Cancer diagnosis and immunotherapy in the age of CRISPR. Genes, Chromosomes and Cancer 58, 233-243.
Ventura A. and Dow L. Modeling Cancer in the CRISPR Era. Annual Review of Cancer Biology. Vol. 2 Issue 1. 2018
Ventura A. NORAD: Defender of the Genome. Trends in genetics : TIG. 2016;32(7):390-2. PubMed PMID: 27157388.
Maddalo D. and Andrea Ventura. Somatic engineering of oncogenic chromosomal rearrangements: a perspective. Cancer Research 2016 Sep 1;76(17):4918-23. Epub 2016 Aug 12. Review. PubMed PMID: 27520450; PubMed Central PMCID: PMC5010508.
Li, X., Wu, R. and Andrea Ventura. The present and future of genome editing in cancer research. Human Genetics. 2016 Sep;135(9):1083-92. Epub 2016 Jul 18.
Andrea Ventura. NORAD: Defender of the genome. Trends in Genetics 32:390-2 (2016). PMID: 27157388
Kannan R and Andrea Ventura. The CRISPR revolution and its impact on cancer research. Swiss Medical Weekly 2015 Dec 10;145:w14230. doi: 10.4414/smw.2015.14230. eCollection 2015. PubMed PMID: 26661454.
Vidigal JA, Andrea Ventura. The biological functions of miRNAs: lessons from in vivo studies. Trends in Cell Biology 2014 Dec 4. pii: S0962-8924(14)00197-4. doi: 10.1016/j.tcb.2014.11.004. [Epub ahead of print] Review. PubMed PMID: 25484347.
Yoon-Chi Han and Andrea Ventura. Control of T(FH) differentiation by a microRNA cluster. Nature Immunology 14, 770-771 (2013).
Joana Alves Vidigal and Andrea Ventura. Embryonic stem cell miRNAs and their roles in development and disease. Seminars in Cancer Biology 22, 428-436 (2012). PMCID: PMC3426648.
Carla P. Concepcion, Ciro Bonetti and Andrea Ventura. The microRNA-17-92 family of microRNA clusters in development and disease. The Cancer Journal 18, 262-267 (2012). PMCID: PMC3592780.
Julien Sage and Andrea Ventura. miR than meets the eye. Genes & Development 25, 1663-1667 (2011). PMCID: PMC3165930
Andrea Ventura and Tyler Jacks. MicroRNAs and cancer: short RNAs go a long way. Cell136, 586-591 (2009). PMCID: PMC3910108
Peter Sandy,Andrea Ventura and Tyler Jacks. Mammalian RNAi: a practical guide. BioTechniques39, 215-224 (2005).
Andrea Ventura and Pier Giuseppe Pelicci. Semaphorins: green light for redox signaling? Sci. STKE 2002, pe44 (2002).
Books and chapters
Ventura, A., Kumar, M. S. & Jacks, T. 24 Roles of microRNAs in cancer and development. MicroRNAs: from basic science to disease biology, 322 (2008).